[1]熊训雅,胡君娥,严妍.肿瘤患者化疗相关味觉改变的研究进展[J].三才(TM)期刊,2019,29(6):81-84.
点击复制

肿瘤患者化疗相关味觉改变的研究进展
分享到:

《三才(TM)期刊》[ISSN:1008-0341/CN:37-1280/R]

卷:
第29卷
期数:
2019年第6期
页码:
81-84
栏目:
其他
出版日期:
2019-08-25

文章信息/Info

文章编号:
1673 1409 (2019)06 0081 04
作者:
熊训雅胡君娥 严妍
长江大学医学部, 湖北荆州434023长江大学第二临床医学院荆州市中心医院肿瘤科, 湖北荆州434000
关键词:
肿瘤化疗味觉改变综述
分类号:
R730
文献标志码:
A
摘要:
对肿瘤患者化疗相关味觉改变的概念、发生率、分类、影响因素、测评工具和干预措施进行综 述,建议护理人员应提高对肿瘤患者化疗相关味觉改变的认知,拓展研究内容,丰富研究方法,合理使 用测评工具,准确评估高危因素,积极实施预见性护理,进一步开展具有针对性的护理干预策略研究。

参考文献/References:


[1]TorreLA,BrayF,SiegelRL,etal.Globalcancerstatistics,2012[J].CACancerJClin,2015,65 (2):87~108.
[2]曾磊. 凋亡肿瘤细胞对小鼠免疫状态的影响及机制研究[D]. 广州:南方医科大学,2014.
[3]HovanAJ,WilliamsPM,StevensonMooreP,etal. Asystematicreviewofdysgeusiainducedbycancertherapies[J].Support CareCancer,2010,18 (8):1081~1087.
[4]GamperE M,ZaberniggA,WintnerL M,etal.Comingtoyoursenses:detectingtasteandsmellalterationsinchemotherapypatients, Asystematicreview [J].JPainSymptom Manage,2012,44 (6):880~895.
[5]钱立晶,路潜,杨萍,等. 肿瘤患者化疗相关性味觉改变调查分析[J]. 护理学杂志,2017,32 (3):27~31.
[6]钱立晶,路潜. 肿瘤患者化疗相关性味觉改变的研究进展[J]. 中华护理杂志,2016,51 (5):547~550.
[7]雷招宝. 药源性味觉障碍[J]. 药物不良反应杂志,2009,11 (3):191~195.
[8]华健,彭秋琴,郭伟剑,等. 结肠癌患者奥沙利铂治疗体验的质性研究[J]. 护理学杂志,2011,26 (2):35~37.
[9]王硕,许可敏,刘江南,等. 肿瘤患者的味觉改变[J]. 肿瘤代谢与营养电子杂志,2015,2 (4):69~75.
[10]KoizumiT,FukushimaT,TataiT,etal.Successfultreatmentofcrizotinib-induceddysgeusiabyswitchingtoalectinibinALK-positivenon- smallcelllungcancer[J].LungCancer,2015,88 (1):112~113.
[11]宋晋萍. 肠内营养治疗在恶性肿瘤化疗患者中的应用效果分析[J]. 中国药物与临床,2014 (12):1731~1732.
[12]ZaberniggA,GamperE M,GiesingerJ M,etal. Tastealterationsincancerpatientsreceivingchemotherapy:aneglectedside effect? [J].Oncologist,2010,15 (8):913~920.
[13]BoltongA,KeastR,ArandaS.Experiencesandconsequencesofalteredtaste,flavourandfoodhedonicsduringchemitherapytreatment[ J].SupportCareCancer,2012,20 (11):2765~2774.
[14]IjpmaI,RenkenRJ,TerHorstGJ,etal. MetallicTasteinCancerPatientsTreatedwithChemotherapy[J].CancerTreatRev, 2015,41 (2):179~186.
[15]SteinbachS,HummelT,BohnerC,etal. Qualitativeandquantitativeassessmentoftasteandsmellchangesinpatientsundergoing chemotherapyforbreastcancerorgynecologicmalignancies[J].JClinOncol,2009,27 (11):1899~1905.
[16]YamagataT,NakamuraY,YamagataY,etal.ThePilotTrialofthePreventionoftheIncreaseinElectricalTasteThresholdsby ZincContainingFluidInfusionduringChemotherapytoTreatPrimaryLungCancer[J].JExpClinCancerRes,2003,22 (4): 557~563.
[17]陆洋宇,席苒珲,郑欣,等. 味觉受体信号转导机制及对微生物的调控[J]. 华西口腔医学杂志,2017,35 (5):549~554.
[18]吴婷,侯云霞,阎玲. 肿瘤化疗患者味觉改变评估及干预研究进展[J]. 护理学报,2018,25 (4):32~36.
[19]KanoT,KandaK. Developmentandvalidationofachemotherapy-inducedtastealterationscale[J]. OncologyNursingForum, 2013,40 (2):E79.
[20]XinL,YangX,CaiG,etal.SerumLevelsofCopperandZincinPatientswithRheumatoidArthritis:aMeta-analysis[J].BiologicalTraceElementResearch, 2015,168 (1):1.
[21]McgreevyJ,OrrevallY,BelqaidK,etal.Characteristicsoftasteandsmellalterationsreportedbypatientsafterstartingtreatment forlungcancer[J].SupportCareCancer,2014,22 (10):2635~2644.
[22]NishijimaS,YanaseT,TsunekiI,etal.Examinationofthetastedisorderassociatedwithgynecologicalcancerchemotherapy[J]. GynecolOncol,2013,131 (3):674~678.
[23]HirooI,HiroshiS,KeigoK,etal.Preliminaryestimationoftheprevalenceofchemotherapy-induceddysgeusiainJapanesepatients withcancer[J].BMCPalliativeCare,2013,12 (1):38.
[24]LauraM L.Tastedysfunctioninheadandneckcancersurvivors [A]. Oncologynursingforum [C].2013:4~13.
[25]Lyckholm L,HeddingerSP,ParkerG,etal. A Randomized,PlaceboControlledTrialofOralZincforChemotherapy-Related TasteandSmellDisorders[J]. HospiceJournal,2012,26 (2):111~114.
[26]RehwaldtM,WickhamR,PurlS,etal.Self-carestrategiestocopewithtastechangesafterchemotherapy[J]. OncologyNursing Forum,2009,36 (2):47~56

更新日期/Last Update: 2019-06-25